Long-term protective effects of methamphetamine preconditioning against single-day methamphetamine toxic challenges

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 35-39

  Hodges, A B ^a,b   Ladenheim, B ^a   McCoy, M T ^a   Beauvais, G ^a   Cai, N ^a   Krasnova, I N ^a   Cadet, J L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b MORGAN STATE UNIVERSITY   (United States)

Author keywords

Dopamine; Methamphetamine; Preconditioning; Striatum

Indexed keywords

DOPAMINE; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DOSE ESCALATION; LONG TERM CARE; MALE; MONOAMINERGIC SYSTEM; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

EID: 79953040734     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017344     Document Type: Article

References (28)

1. Degenhardt, L., Baker, A., Maher, L. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Drug Alcohol Rev., 2008, 27(3), 217-219.
2. Maxwell, J. C., Rutkowski, B. A. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev., 2008, 27(3), 229-235.
3. Darke, S., Kaye, S., McKetin, R., Duflou, J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev., 2008, 27(3), 253-262.
4. Meredith, C. W., Jaffe, C., Ang-Lee, K., Saxon, A. J. Implications of chronic methamphetamine use: a literature review. Harv. Rev. Psychiatry, 2005, 13(3), 141-154.
5. Chang, L., Alicata, D., Ernst, T., Volkow, N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 2007, 102(Suppl 1), 16-32.
6. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y. S., Logan, J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci., 2001, 21(23), 9414-9418.
7. Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., Tsuchiya, K. J., Tsukada, H., Iyo, M., Mori, N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch. Gen. Psychiatry, 2006, 63(1), 90-100.
8. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., Kish, S. J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med., 1996, 2(6), 699-703
9. Krasnova, I. N., Cadet, J. L. Methamphetamine toxicity and messengers of death. Brain Res. Rev., 2009, 60(2), 379-407.
10. Friedman, S. D., Castaneda, E., Hodge, G. K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav., 1998, 61(1), 35-44.
11. Cadet, J. L., Krasnova, I. N. Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox. Res., 2007, 12(3), 181-204.
12. Cadet, J. L., Krasnova, I. N., Jayanthi, S., & Lyles, J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res., 2007, 11(3-4), 183-202.
13. Deng, X., Ladenheim, B., Jayanthi, S., Cadet, J. L. Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb. Biol. Psychiatry, 2007, 61(11), 1235-1243
14. Cadet, J. L., Jayanthi, S., Deng, X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J., 2003, 17(13), 1775-1788.
15. Cho, A. K., Melega, W. P. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis., 2002, 21(1), 21-34.
16. Kramer, J. C., Fischman, V. S., Littlefield, D. C. Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA, 1967, 201(5), 305-309.
17. Cadet, J. L., Krasnova, I. N., Ladenheim, B., Cai, N. S., McCoy, M. T., Atianjoh, F. E. Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox. Res., 2009, 15(3), 252-259.
18. Danaceau, J. P., Deering, C. E., Day, J. E., Smeal, S. J., Johnson-Davis, K. L., Fleckenstein, A. E., Wilkins, D. G. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur. J. Pharmacol., 2007, 559(1), 46-54.
19. Graham, D. L., Noailles, P. A., Cadet, J. L. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J. Neurochem., 2008, 105(5), 1873-1885.
20. Gygi, M. P., Gygi, S. P., Johnson, M., Wilkins, D. G., Gibb, J. W., Hanson, G. R. Mechanisms for tolerance to methamphetamine effects. Neuropharmacology, 1996, 35(6), 751-757.
21. Johnson-Davis, K. L., Fleckenstein, A. E., Wilkins, D. G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur. J. Pharmacol., 2003, 482(1-3), 151-154.
22. Krasnova, I. N., Bychkov, E. R., Lioudyno, V. I., Zubareva, O. E., Dambinova, S. A. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopaminelesioned rats. Neuroscience, 2000, 95(1), 113-117.
23. Johnson-Davis, K. L., Truong, J. G., Fleckenstein, A. E., Wilkins, D. G. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther., 2004, 309(2), 578-586.
24. Schmidt, C. J., Sonsalla, P. K., Hanson, G. R., Peat, M. A., Gibb, J. W. Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J. Neurochem., 1985, 44(3), 852-855.
25. Segal, D. S., Kuczenski, R., O'Neil, M. L., Melega, W. P., Cho, A. K. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology, 2003, 28(10), 1730-1740.
26. O'Neil, M. L., Kuczenski, R., Segal, D. S., Cho, A. K., Lacan, G., Melega, W. P. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse, 2006, 60(6), 465-473.
27. Hanson, J. E., Birdsall, E., Seferian, K. S., Crosby, M. A., Keefe, K. A., Gibb, J. W., Hanson, G. R., Fleckenstein, A. E. Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment. Eur. J. Pharmacol., 2009, 607(1-3), 68-73.
28. Cadet, J. L., Krasnova, I. N. Cellular and molecular neurobiology of brain preconditioning. Mol. Neurobiol., 2009, 39(1), 50-61.